Cita APA (7a ed.)

Morita-Fujita, M., Arai, Y., Yoshioka, S., Ishikawa, T., Kanda, J., Kondo, T., . . . (KSCTG), K. S. C. T. G. (2020). Indication and benefit of upfront hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma in the era of ALL-type induction therapies. Nature Portfolio.

Cita Chicago Style (17a ed.)

Morita-Fujita, Mari, et al. Indication and Benefit of Upfront Hematopoietic Stem Cell Transplantation for T-cell Lymphoblastic Lymphoma in the Era of ALL-type Induction Therapies. Nature Portfolio, 2020.

Cita MLA (8a ed.)

Morita-Fujita, Mari, et al. Indication and Benefit of Upfront Hematopoietic Stem Cell Transplantation for T-cell Lymphoblastic Lymphoma in the Era of ALL-type Induction Therapies. Nature Portfolio, 2020.